Guiding the future of precision medicine through clinical excellence, education, genomics, AI innovation, and global health leadership.
Dr. Matthew Taylor is a board-certified family physician and a leading practitioner of P4 precision medicine, known for mentoring physicians in integrative and personalized medicine internationally.
He earned his medical degree from Wayne State University School of Medicine and completed family medicine training at UPMC Altoona and the University of Maryland Medical Center.
His continuing education spans numerous advanced programs including the National Lipidology Association, SSRP Cellular Medicine Fellowship, the Institute for Functional Medicine, Trauma Research Foundation, NICABM, and the International Society for Environmentally Acquired Illness.
As co-founder of the American Board of Precision Medicine, he contributes clinical leadership and strategic insight to the organization’s educational initiatives and physician training programs.
LinkedIn
Dr. Yazdi is a physician-scientist and entrepreneur specializing in genomics, bioinformatics, and AI-driven precision medicine innovation.
He completed medical training at USC and residency at Stanford University and later became a Clinical Fellow in regenerative medicine at UC Irvine.
As founder of Systomic Health and leader at SelfDecode, he has pioneered genomic technologies used by biotechnology companies and global health platforms.
His work focuses on translating advanced genomic science into scalable healthcare solutions worldwide.
LinkedInRalph Kenney is a senior executive specializing in health technology, strategic growth, and AI-driven precision health platforms.
As COO and CFO of SelfDecode he built a B2B division generating over $100M in contracts and helped expand the company’s genomics platform worldwide.
Previously he served as COO of R Systems Inc., scaling operations dramatically and leading the company through a successful IPO.
Earlier leadership roles at AT&T involved managing business units with more than $150M in annual revenue.
LinkedInModern medicine increasingly recognizes that disease is driven by complex biological interactions rather than single genetic or molecular abnormalities. Multi-omics science integrates multiple biological layers to provide a comprehensive molecular understanding of health and disease.
Genomics – The study of DNA and genetic variation that influences disease risk and treatment response.
Transcriptomics – Analysis of gene expression patterns that reveal how cells respond to disease processes.
Proteomics – Investigation of protein structures and interactions that drive biological function.
Metabolomics – Measurement of metabolic pathways that reflect cellular activity and disease states.
Microbiomics – Understanding the role of the human microbiome in immune regulation, metabolism, and chronic disease.
Explore ABOPM perspectives on genomics, multi-omics, systems thinking, clinical innovation, and the future of physician leadership in precision medicine.
Genomic diversity is essential for accurate, equitable precision medicine. Expanding representation in research improves risk prediction, variant interpretation, and ensures better outcomes for all po... ...more
Population Precision
April 23, 2026•8 min read

Multi-omics medicine integrates genomics, transcriptomics, proteomics, and metabolomics to provide a comprehensive view of disease biology. By analyzing multiple molecular layers together, it enables ... ...more
On the Frontier
April 15, 2026•8 min read

Advances in biomedical research have significantly expanded the role of molecular and physiological indicators in clinical decision-making. Among the most influential of these developments is the incr... ...more
Precision Medicine in Action
April 08, 2026•8 min read

Subscribe to receive ABOPM insights, research updates, and educational resources delivered directly to your inbox.
© 2023-2025 American Board of Precision Medicine, Inc. All Rights Reserved.